copy of dr. naidoo on managing immune-related adverse events in nsclc
Published 5 years ago • 34 plays • Length 0:15Download video MP4
Download video MP3
Similar videos
-
1:26
dr. naidoo on managing immune-related adverse events in nsclc
-
1:34
dr. naidoo on the mechanisms behind immune-related adverse events in lung cancer
-
2:35
dr. naidoo discusses the management of immune-related adverse events in lung cancer
-
1:35
dr. naidoo on studies of immune-related adverse events in lung cancer
-
1:03
dr. naidoo on treating immune-related adverse events in nsclc
-
1:25
immune-related adverse events: what to know
-
5:21
pd-l1 immune-related adverse events
-
1:14
dr. sabari on managing immune-related adverse events in lung cancer
-
![disturbed - the sound of silence (official music video) [4k upgrade]](https://i.ytimg.com/vi/u9Dg-g7t2l4/mqdefault.jpg)
4:23
disturbed - the sound of silence (official music video) [4k upgrade]
-
15:51
introduction to immunotherapy (immunotherapy documentary part i)
-
3:29
pd-l1/pd-1 pathway: a security checkpoint
-
1:41
dr. naidoo on considerations for managing iraes in nsclc
-
21:59
monitoring, managing, and mitigating immune-related adverse events
-
0:45
it takes a team: treating adverse events
-
1:02
dr. borghaei on immune-related adverse events in lung cancer
-
1:02:47
“rheumatologic consequences of immune checkpoint inhibitors”, annual kessler lecture, dr. ami shah
-
0:29
copy of dr. wei on immune-related adverse events in gu cancers
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
14:42
managing toxicities associated with immune-checkpoint inhibitors
-
1:57
managing the adverse events of immune checkpoint inhibitors
-
2:45
correlation between cutaneous immune-related adverse events and os with immune checkpoint inhibitors
-
22:28
part 6 - immune related adverse events with pdl1 and ctla4 inhibitors - dr. raya leibowitz, israel